Rival lab platforms, side by side

Eight pairs of rival platforms, compared by how many bioRxiv and medRxiv preprints say they used each. The closest race in the last 6 months: Revio vs PromethION, used in 195 and 285 preprints. Updated daily (as of Nov 16)

Spatial biology

Xenium 10x Genomics 146
spatial
CosMx Bruker (NanoString) 37
Xenium 10x Genomics 146
spatial
MERSCOPE Vizgen 20
Visium 10x Genomics 175
spatial
GeoMx Bruker (NanoString) 47

Single-cell

Chromium 10x Genomics 1,044
single-cell
Evercode Parse (QIAGEN) 69

Short-read sequencing

AVITI Element Biosciences 171
short-read
NovaSeq X Illumina 1,309

Long-read sequencing

Revio PacBio 195
long-read
PromethION Oxford Nanopore 285

Mass-spec proteomics

Orbitrap Astral Thermo Fisher 212
mass spec
timsTOF Bruker 380

Affinity proteomics

Olink Thermo Fisher 92
affinity proteomics
SomaScan SomaLogic (Illumina) 34
How we count which preprints use each platform

An AI model reads each preprint in full — its text, its tables and its supplementary files — and lists the products the authors used. A preprint counts for a platform when that record says the lab used it in this work, not when it only analyzed data others made with it or only mentioned it. Each preprint counts once, by its first version, if it was first posted on bioRxiv or medRxiv in April 2025 or later. We read new preprints within days of posting, so the newest ones (through Nov 16, 2026) are already counted, but those days are not complete yet. Six-month counts and growth figures stop at Nov 12, 2026, the last day nearly every preprint has been read, and charts draw a quarter that is still being counted in a paler color. A preprint that used two platforms counts for both. Each title links to the preprint on bioRxiv or medRxiv; we show no preprint text and no author names. Updated daily, most recently on Nov 16, 2026.